Main Markets: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
Exporter:51% - 60%
Certs:COS, ISO9001, CE, PSE, UL
Description:Antineoplastic drugs CAS 59-05-2,Price details Methotrexate,Methotrexate CAS NO 59-05-2
